February 22, 2018 / 2:46 AM / 8 months ago

BRIEF-Mizuho Medy obtains marketing and manufacture approval of mycoplasma nucleic acid kit for genetic POCT examination

Feb 22 (Reuters) - Mizuho Medy Co Ltd

* Says it obtained the marketing and manufacture approval of mycoplasma nucleic acid kit for genetic POCT examination in Japan on Feb. 19

Source text in Japanese:goo.gl/LVabQk

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below